Raymond James Trust’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,800
Closed -$277K 1214
2023
Q3
$277K Hold
16,800
0.01% 904
2023
Q2
$304K Hold
16,800
0.01% 888
2023
Q1
$314K Hold
16,800
0.01% 844
2022
Q4
$263K Hold
16,800
0.01% 898
2022
Q3
$297K Hold
16,800
0.01% 793
2022
Q2
$330K Hold
16,800
0.01% 756
2022
Q1
$493K Sell
16,800
-700
-4% -$20.9K 0.02% 648
2021
Q4
$681K Buy
17,500
+581
+3% +$23.2K 0.02% 539
2021
Q3
$653K Hold
16,919
0.02% 527
2021
Q2
$705K Sell
16,919
-1,849
-10% -$70.1K 0.02% 495
2021
Q1
$670K Buy
18,768
+5,049
+37% +$184K 0.02% 478
2020
Q4
$499K Sell
13,719
-9
-0.1% -$277 0.02% 541
2020
Q3
$352K Sell
13,728
-2,272
-14% -$56.7K 0.02% 627
2020
Q2
$363K Buy
16,000
+1,000
+7% +$20.3K 0.02% 579
2020
Q1
$250K Hold
15,000
0.01% 622
2019
Q4
$308K Hold
15,000
0.01% 674
2019
Q3
$311K Buy
+15,000
New +$319K 0.02% 645

Other funds holding BSTZ

Raymond James Trust's BSTZ Position: Q4 2023 in Review

Raymond James Trust sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q4 2023, closing a stake of 16,800 shares — an estimated $277K sold.

Raymond James Trust first reported a position in BSTZ in Q3 2019 and held it in 17 quarters. The position peaked at $705K in Q2 2021. 107 funds tracked by Wall St. Rank hold BSTZ as of Q4 2023.

  • Raymond James Trust reported no remaining BlackRock Science and Technology Term Trust position as of Q4 2023 after selling out during the quarter.
  • Raymond James Trust sold 16,800 BlackRock Science and Technology Term Trust shares in Q4 2023, an estimated $277K.
  • Raymond James Trust first reported a position in BlackRock Science and Technology Term Trust in Q3 2019 and held it in 17 quarters.
  • Raymond James Trust's BlackRock Science and Technology Term Trust position peaked at $705K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q4 2023.

Based on Raymond James Trust's 13F filing for Q4 2023, filed 10 Jan 2024.